Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05276206Phase 1Completed
Phase 1, randomised trial of nalbuphine in postoperative pain (4 arms), sponsored by Egymedicalpedia. Primary endpoint: Post Operative Pain at 2 hours. Started Mar 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05276206.